Frontlight ResearchEarly access
Pancreatic cancer trials in United States
405 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 1Taking peopleT Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
- Where
- Seattle
- Age
- 18 years and over
- People
- 24
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06043713 - Phase 2Not yet taking people in United StatesTemozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
- Where
- Buffalo
- Age
- 18 years and over
- People
- 60
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06202066 - No phaseTaking peopleEUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
- Where
- Orlando
- Age
- 18 years to 100 years
- People
- 140
- Run by
- Orlando Health, Inc.
See details and how to joinNCT06340620 - Phase 1Taking peopleSafety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Where
- Atlanta, Denver, Los Angeles, Milwaukee, Newport, New York, Rochester, San Antonio
- Age
- 18 years and over
- People
- 100
- Run by
- Nammi Therapeutics Inc
See details and how to joinNCT06582017 - Phase 1/2Taking peoplePhase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- Where
- Duarte, Fairfax, Santa Monica
- Age
- 18 years and over
- People
- 164
- Run by
- BigHat Biosciences, Inc.
See details and how to joinNCT07529808 - No phaseTaking peopleEUS Procedures Using RIVOS™ EUS Access Device
- Where
- Orlando
- Age
- 18 years and over
- People
- 30
- Run by
- Orlando Health, Inc.
See details and how to joinNCT07696572 - No phaseTaking peopleDCE-MRI Guided Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer
- Where
- Columbus, Indianapolis
- Age
- 19 years and over
- People
- 50
- Run by
- Ohio State University
See details and how to joinNCT06173310 - Phase 1/2Taking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Aurora, Durham, Houston, Los Alamitos, Los Angeles, Madison, New York, San Antonio, Santa Monica, Wenatchee, Whittier
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - Phase 2Taking peopleNatural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors
- Where
- Bethesda
- Age
- 12 years and over
- People
- 740
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04074135 - No phaseEnrolling by invitationProspective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment
- Where
- Bethesda
- Age
- 18 years and over
- People
- 1,200
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05600933 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Huntersville, Irving
- Age
- 18 years and over
- People
- 130
- Run by
- AbbVie
See details and how to joinNCT07807956 · EU 2026-526097-17-00 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1/2Taking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Denver, Detroit, New York, Orlando
- Age
- 18 years and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - Phase 1Taking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Boston, Celebration, Columbus, Dallas, Denver, Detroit, Houston, Iowa City, Jacksonville, Los Angeles, Madison, Nashville, New Brunswick, Oklahoma City, Phoenix, Pittsburgh, Rochester, Sarasota, St Louis, Tucson
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - Phase 1Taking peopleStudy to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400
- Where
- Aurora, Charleston, Chicago, Cleveland, Denver, Duarte, Durham, Fairfax, Grand Rapids, Greenville, Houston, Nashville, New York, Providence, San Antonio, San Francisco, Sarasota, St Louis
- Age
- 18 years and over
- People
- 325 worldwide
- Run by
- AbbVie
See details and how to joinNCT06084481 · EU 2023-506227-29-00 - Phase 2Taking peopleMedical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
- Where
- Saint Louis Park
- Age
- 18 years and over
- People
- 64
- Run by
- HealthPartners Institute
See details and how to joinNCT06605430 - Phase 2/3Taking peopleA Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Where
- ‘Aiea, Athens, Baltimore, Birmingham, Bryant, Chapel Hill, Charlotte, Conway, Dallas, Decatur, Encinitas, Hillsborough, Hinsdale, Honolulu, Houston, Irvine, Jacksonville, Kansas City, La Jolla, Lenexa, Lexington, Little Rock, Los Angeles, Merriam, Milwaukee, Morristown, Nashville, New Brunswick, New Lenox, New York, North Little Rock, O'Fallon, Omaha, Orange, Phoenix, Pine Bluff, Portland, Reno, Richmond, Rochester, San Diego, Santa Monica, Santa Rosa, Seattle, Somerville, Summit, Tappahannock, Temple, Vista, Washington D.C.
- Age
- 18 years and over
- People
- 982 worldwide
- Run by
- Pfizer
See details and how to joinNCT06989437 · EU 2025-522093-36-00 - No phaseTaking peopleA Screening Program to Improve the Early Detection of Sporadic Pancreatic Cancer in Individuals With a High-Risk of Developing Pancreatic Cancer
- Where
- Rochester
- Age
- 50 years to 85 years
- People
- 100
- Run by
- Mayo Clinic
See details and how to joinNCT07324096 - No phaseTaking peopleEvaluating Intermittent Fasting In Individuals At High Risk ForPancreatic Cancer Undergoing Screening
- Where
- Houston
- Age
- 18 years and over
- People
- 20
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07513116 - Phase 1Taking peopleTCR1188-ABC Cells in KRAS-mutated Cancers
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- University of Pennsylvania
See details and how to joinNCT07594067 - No phaseTaking peopleConfocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
- Where
- Baltimore, Boston, Columbus, Fort Wayne, Garden City, Houston, New Haven, New York, Scottsdale, Stanford
- Age
- 18 years and over
- People
- 500
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT03492151 - Phase 2Taking peopleMaintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy
- Where
- Boston, Philadelphia
- Age
- 18 years and over
- People
- 68
- Run by
- Abramson Cancer Center at Penn Medicine
See details and how to joinNCT06747845 - Phase 2Taking peopleAcoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
- Where
- Boston, Detroit, Philadelphia, Pittsburgh, Providence, Scottsdale, Stanford
- Age
- 18 years and over
- People
- 25 worldwide
- Run by
- EXACT Therapeutics AS
See details and how to joinNCT06850623 - No phaseEnrolling by invitationEndoscopic Ultrasound-Guided Pulsed Electric Field Ablation for the Treatment of Pancreatic Neoplasms
- Where
- Columbus
- Age
- 18 years and over
- People
- 12
- Run by
- Ohio State University Comprehensive Cancer Center
See details and how to joinNCT07619417 - Phase 2Taking peopleA Study to Assess Adverse Events and Change in Disease Activity With Treatment Combinations With Telisotuzumab Adizutecan in Adults Participants With Pancreatobiliary Cancers
- Where
- Hattiesburg
- Age
- 18 years and over
- People
- 168 worldwide
- Run by
- AbbVie
See details and how to joinNCT07769502 · EU 2025-524801-33-00